KLTO (Klotho Neurosciences) EBITDA Margin % : 0.00% (As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Klotho Neurosciences EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Klotho Neurosciences's EBITDA for the three months ended in Sep. 2024 was $-2.91 Mil. Klotho Neurosciences's Revenue for the three months ended in Sep. 2024 was $0.00 Mil. Therefore, Klotho Neurosciences's EBITDA margin for the quarter that ended in Sep. 2024 was 0.00%.

Klotho Neurosciences EBITDA Margin % Historical Data

The historical data trend for Klotho Neurosciences's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Klotho Neurosciences EBITDA Margin % Chart

Klotho Neurosciences Annual Data

Trend

Dec21

Dec22

EBITDA Margin %

Klotho Neurosciences Quarterly Data
	Dec21	Jun22	Dec22	Jun23	Sep23	Mar24	Jun24	Sep24
EBITDA Margin %	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Klotho Neurosciences's EBITDA Margin %

For the Biotechnology subindustry, Klotho Neurosciences's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Klotho Neurosciences's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Klotho Neurosciences's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Klotho Neurosciences's EBITDA Margin % falls into.

Save Embed

;

Save Embed

;

Klotho Neurosciences EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Klotho Neurosciences's EBITDA Margin % for the fiscal year that ended in Dec. 2022 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2022 )	/	Revenue (A: Dec. 2022 )
	=	-0.574	/	0
	=	%

Klotho Neurosciences's EBITDA Margin % for the quarter that ended in Sep. 2024 is calculated as

EBITDA Margin %	=	EBITDA (Q: Sep. 2024 )	/	Revenue (Q: Sep. 2024 )
	=	-2.914	/	0
	=	%

Klotho Neurosciences (NAS:KLTO) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Klotho Neurosciences EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Klotho Neurosciences's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Klotho Neurosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Klotho Neurosciences Inc (NAS:KLTO) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

13576 Walnut Street, 12th Floor, Omaha, NE, USA, 68144

Website

https://www.klothoneuro.com

Klotho Neurosciences Inc is in the development of patented, novel disease-modifying technologies targeting the brain and central nervous system (CNS) that are seen as key developments in treating neurodegenerative and age-related disorders.